(Q52075813)

21 April 2018

title

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. (English)

1 reference

21 April 2018

0 references

0 references

Robnett TJ

1

1 reference

21 April 2018

Machtay M

2

1 reference

21 April 2018

Vines EF

3

1 reference

21 April 2018

McKenna MG

4

1 reference

21 April 2018

Algazy KM

5

1 reference

21 April 2018

McKenna WG

6

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

21 April 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

21 April 2018

volume

48

1 reference

21 April 2018

issue

1

1 reference

21 April 2018

page(s)

89-94

1 reference

21 April 2018

The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer. West Japan Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

CHRONIC BRONCHITIS AND RADIOTHERAPY OF THE LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

SEQUELAE OF RADICAL RADIOTHERAPY OF CARCINOMA OF THE LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

The effect of dose rate and adriamycin on the tolerance of thoracic radiation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Dose escalation for non-small cell lung cancer using conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

10.1016/S0360-3016(00)00648-9

Identifiers

DOI

1 reference

21 April 2018

PubMed ID

10924976

1 reference

21 April 2018